Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function
Open Access
- 1 December 2006
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (50) , 38812-38824
- https://doi.org/10.1074/jbc.m602494200
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either ReceptorMolecular Pharmacology, 2005
- Cannabinoid receptor homo- and heterodimerizationLife Sciences, 2005
- Dimer-based model for heptaspanning membrane receptorsTrends in Biochemical Sciences, 2005
- G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 ReceptorCirculation, 2005
- Anorexia and weight loss in male rats 24h following single dose treatment with orexin-1 receptor antagonist SB-334867Behavioural Brain Research, 2005
- Characterisation of the binding of [3H]‐SB‐674042, a novel nonpeptide antagonist, to the human orexin‐1 receptorBritish Journal of Pharmacology, 2004
- GPCR dimerisationLife Sciences, 2003
- The Receptors for Mammalian Sweet and Umami TastePublished by Elsevier ,2003
- The Role of Hypocretins (Orexins) in Sleep Regulation and NarcolepsyAnnual Review of Neuroscience, 2002
- Dopamine D2 Receptor Dimer FormationJournal of Biological Chemistry, 2001